Meeting
2022 ASCO Annual Meeting
Hair Safe Study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer therapy—A prospective interventional study.
Authors
Christine Brunner
Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria
Christine Brunner , Ricarda Kofler , Daniel Egle , Verena Wieser , Magdalena Ritter , Samira Abdel Azim , Marlene Lehmann , Miriam Elisabeth Emmelheinz , Christian Marth
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 12093)
DOI
10.1200/JCO.2022.40.16_suppl.12093
Abstract #
12093
Poster Bd #
339
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Investigating keratinocyte growth factor hair serum for the prevention of chemotherapy-induced alopecia.
First Author: Preethika Potluri
Poster
2022 ASCO Annual Meeting
CT scan versus bioelectrical impedance spectrometry sarcopenia assessment to predict chemotherapy toxicity in early breast cancer.
First Author: Gabriel Aleixo
Poster
2019 ASCO Annual Meeting
The CAROLE (CArdiac Related Oncologic Late Effects) Study: A Phase II, single-arm feasibility trial.
First Author: Lindsay Puckett
Poster
2017 ASCO Annual Meeting
Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer.
First Author: Julie R. Nangia